Combined effects of simvastatin and fibroblast growth factor-2 on the proliferation and differentiation of preosteoblasts.

about

Combined effects of simvastatin and fibroblast growth factor-2 on the proliferation and differentiation of preosteoblasts.

Item

http://www.wikidata.org/entity/Q39227057

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Combined effects of simvastati ...... erentiation of preosteoblasts.

@en

Combined effects of simvastati ...... erentiation of preosteoblasts.

@nl

type

Item

label

Combined effects of simvastati ...... erentiation of preosteoblasts.

@en

Combined effects of simvastati ...... erentiation of preosteoblasts.

@nl

prefLabel

Combined effects of simvastati ...... erentiation of preosteoblasts.

@en

Combined effects of simvastati ...... erentiation of preosteoblasts.

@nl

P1476

Combined effects of simvastati ...... erentiation of preosteoblasts.

@en

P2093

Jun-Beom Park

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular and cellular determinants of estrogen receptor alpha expression.

The use of simvastatin in bone regeneration.

Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.

Transcriptional regulation of the human bone sialoprotein gene by fibroblast growth factor 2.

The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression.

Stimulation of bone formation in vitro and in rodents by statins.

Combination of simvastatin and bone morphogenetic protein-2 enhances the differentiation of osteoblasts by regulating the expression of phospho-Smad1/5/8

Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss.

Low dose of doxycyline promotes early differentiation of preosteoblasts by partially regulating the expression of estrogen receptors.

Simvastatin maintains osteoblastic viability while promoting differentiation by partially regulating the expressions of estrogen receptors α.

P304

812-814

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2013.137

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24649034

http://www.w3.org/2001/XMLSchema#string

P932

3917103

http://www.w3.org/2001/XMLSchema#string